NCT04676841

Brief Summary

In the present study we will compare bacteriological findings and the incidence of SSI in relation to laminar airflow (LAF) ventilated ORs, conventional (also called displacement or mixed) ventilated ORs and conventional ventilated ORs with the addition of tables equipped with units providing a local LAF over the surgical instruments. The hypothesis is that there exist a correlation between number and types of airborne bacteria and bacteria in the surgical wound and on surgical instruments at the time of wound closure.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2019

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

November 17, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 21, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2022

Completed
Last Updated

December 21, 2020

Status Verified

November 1, 2020

Enrollment Period

2.2 years

First QC Date

November 17, 2020

Last Update Submit

December 17, 2020

Conditions

Keywords

LAFUDFSSIWound contaminationInfection controlAirborne contaminationOperating room

Outcome Measures

Primary Outcomes (2)

  • Live bacterial Count (colony forming units, CFU) per meter3 air during surgery; in ORs with LAF ventilation, Conventional ventilation or Conventional ventilation + local LAF above instrument tables

    Active airsampling within 30cm from the surgical wound will be performed during surgery and number of collected aerobe and anaerobe bacteria analyzed.

    2019-2021

  • Number of CFU in the surgical wound before closure; after surgery in ORs with LAF ventilation, Conventional ventilation or Conventional ventilation + local LAF above instrument tables

    The entire wound is swabed before closure, aerobe and anaerobe bacteria analyzed.

    2019-2021

Secondary Outcomes (5)

  • CFU/dm2 on the patients skin Before directly prior to incission, before surgery in surgery in ORs with LAF ventilation, Conventional ventilation or Conventional ventilation + local LAF above instrument tables

    2019-2022

  • CFU/dm2 on the instrument tables during surgery in ORs with LAF ventilation, Conventional ventilation or Conventional ventilation + local LAF above instrument tables

    2019-2022

  • Bacterial species in air collected during surgery in ORs with LAF ventilation, Conventional ventilation or Conventional ventilation + local LAF above instrument tables

    2019-2022

  • Bacterial species in wound samples collected during surgery in ORs with LAF ventilation, Conventional ventilation or Conventional ventilation + local LAF above instrument tables

    2019-2022

  • Number and sort of SSI in patients operated in ORs with LAF ventilation, Conventional ventilation or Conventional ventilation + local LAF above instrument tables

    2019-2022

Study Arms (1)

Hemiarthroplasty

Hip fracture patients operated with hemiarthroplasty

Device: Conventional ventilation + instrumental tables with integrated laminar airflowDevice: Conventional ventilation + standard instrumental tablesDevice: Laminar airflow ventilation + standard instrumental tables

Interventions

Surgical instruments protected from contamination by local laminar airflow

Hemiarthroplasty

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hip fracture patients operated with hemiarthroplasty

You may qualify if:

  • Patients undergoing hip fracture surgery treated with hemiarthroplasty implant and that are subsequently cared for at participating ortho-geriatric unit

You may not qualify if:

  • Patients that will not give their informed consent.
  • Patient that, at the time of surgery, have an infection in any part of the body, hospital or community acquired.
  • Patients receiving fracture fixation with pins only

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Ortopedics, Sahlgrenska University Hospital

Mölndal, 43180, Sweden

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Swab samples for microbial analysis. Samples taken from skin before surgery and from surgical wound before closure.

MeSH Terms

Conditions

Surgical Wound InfectionHip FracturesMusculoskeletal Diseases

Condition Hierarchy (Ancestors)

Wound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsFemoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Study Officials

  • Henrik Malchau

    Sahlgrenska University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2020

First Posted

December 21, 2020

Study Start

September 1, 2019

Primary Completion

November 1, 2021

Study Completion

November 1, 2022

Last Updated

December 21, 2020

Record last verified: 2020-11

Locations